Literature DB >> 24271695

Surgical resection versus conformal radiotherapy combined with TACE for resectable hepatocellular carcinoma with portal vein tumor thrombus: a comparative study: reply.

W Y Lau1, W P Zhou.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24271695     DOI： 10.1007/s00268-013-2353-6

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  5 in total

Review 1.  Radioembolization for hepatocellular carcinoma: a review of the evidence and treatment recommendations.

Authors:  Bruno Sangro; Riad Salem; Andrew Kennedy; Douglas Coldwell; Harpreet Wasan
Journal:  Am J Clin Oncol       Date:  2011-08       Impact factor: 2.339

2.  Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres.

Authors:  Wan-Yee Lau; Andrew S Kennedy; Yun Hwan Kim; Hee Kit Lai; Rheun-Chuan Lee; Thomas W T Leung; Ching-Sheng Liu; Riad Salem; Bruno Sangro; Borys Shuter; Shih-Chang Wang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-13       Impact factor: 7.038

3.  Surgical resection versus conformal radiotherapy combined with TACE for resectable hepatocellular carcinoma with portal vein tumor thrombus: a comparative study.

Authors:  Qing-he Tang; Ai-jun Li; Guang-ming Yang; Eric C H Lai; Wei-ping Zhou; Zhi-hao Jiang; Wan Yee Lau; Meng-chao Wu
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

Review 4.  Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: the emerging role for radioembolization using yttrium-90.

Authors:  Wan-Yee Lau; Bruno Sangro; Pier-Jer Chen; Shu-Qun Cheng; Pierce Chow; Rheun-Chuan Lee; Thomas Leung; Kwang-Hyub Han; Ronnie T P Poon
Journal:  Oncology       Date:  2013-04-18       Impact factor: 2.935

5.  Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support.

Authors:  J L Raoul; D Guyader; J F Bretagne; R Duvauferrier; P Bourguet; D Bekhechi; Y M Deugnier; M Gosselin
Journal:  J Nucl Med       Date:  1994-11       Impact factor: 10.057
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.